Bourbon virus infection pathophysiology

Revision as of 16:09, 13 July 2017 by Skazmi (talk | contribs)
Jump to navigation Jump to search

Bourbon virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bourbon virus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

CT

MRI

ECG

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bourbon virus infection pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bourbon virus infection pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bourbon virus infection pathophysiology

CDC on Bourbon virus infection pathophysiology

Bourbon virus infection pathophysiology in the news

Blogs on Bourbon virus infection pathophysiology

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency

Risk calculators and risk factors for Bourbon virus infection pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Pathophysiology

Bourbon virus is a negative sense segmented RNA virus belonging to the genus Thogotovirus, family Orthomyxovirida.

Transmission

  • Boubon virus is transmitted mainly by ticks.
  • The virus is able to replicate in vertebrate and tick cells.

Adherence

  • Virus attaches to the N-acetylneuraminic acid component found in host cell membrane (sialic acid receptors).[1]

Endocytosis

  • The virus gets endocytosed by clathrins into the host cell.
  • Endosome acidification induces fusion of virus membrane with the vesicle membrane.

Virology and replication

  • Thogoto viruses are spherical, enveloped single stranded RNA viruses with a segmented genome.
  • Virions are 80-120nm in diameter with a genome size of approximately 10Kb. The 6-7 segments of genome encodes for 7-9 proteins with each segment size ranging from a low of 0.9Kb to 2.3Kb.
  • Viral RNA polymerases (PA, PB1 and PB2) transcribe one mRNA from each gnome segment .
  • Splicing of segment 6 mRNA gives rise to mRNA coding for the matrix protein M1.
  • Transcription of genomic segments by the viral polymerase produces mRNAs that are capped and polyadenylated by the viral polymerase.
  • The M1 protein is involved in export of genome from the nucleus.
  • Assembly of the virus takes place in the cytoplasm from where new virions are released to infect other cells.

Host response

  • Thogoto Virus Infection induces a sustained type 1 interferon response in the host until the daptive immunity takes effect.[2]
  • IFN expression is mediated by specialized plasmacytoid dendritic cells (pDC).
  • The interferon-induced dynamin-like MxA protein is involved in host antiviral activity against thogoto viruses.[3][4][5]
  • MxA recognizes the nucleocapsids of invading viruses, causing an early block of the viral replication cycle.[3][6]


References

  1. "Receptor-Mediated Endocytosis and the Sorting of Internalized Proteins - Molecular Cell Biology - NCBI Bookshelf".
  2. Kochs G, Bauer S, Vogt C, Frenz T, Tschopp J, Kalinke U, Waibler Z (2010). "Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cells". J. Virol. 84 (23): 12344–50. doi:10.1128/JVI.00931-10. PMC 2976394. PMID 20861272.
  3. 3.0 3.1 Patzina C, Haller O, Kochs G (2014). "Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus". J. Biol. Chem. 289 (9): 6020–7. doi:10.1074/jbc.M113.543892. PMC 3937669. PMID 24448803.
  4. Haller O, Kochs G (2011). "Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity". J. Interferon Cytokine Res. 31 (1): 79–87. doi:10.1089/jir.2010.0076. PMID 21166595.
  5. Frese M, Kochs G, Meier-Dieter U, Siebler J, Haller O (1995). "Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus". J. Virol. 69 (6): 3904–9. PMC 189115. PMID 7745744.
  6. Pavlovic J, Haller O, Staeheli P (1992). "Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle". J. Virol. 66 (4): 2564–9. PMC 289059. PMID 1548781.

Template:WH Template:WS